{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:30:57Z","timestamp":1787009457458,"version":"build-2736575974"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Adjuvant radiotherapy for early-stage breast cancer has progressively shifted toward less extensive treatment approaches. Partial breast irradiation (PBI) has emerged as a safe and effective option for appropriately selected patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To systematically compare PBI versus whole breast irradiation (WBI) in early-stage breast cancer with respect to acute and late toxicity, cosmetic outcomes, quality of life, local disease control, and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review of randomized clinical trials evaluating PBI delivered by any technique versus WBI in early-stage breast cancer. Searches were performed in CENTRAL\/CCTR, EMBASE, MEDLINE, CINAHL, ISRCTN, and ClinicalTrials.gov, following PRISMA 2020 guidelines. Risk of bias was assessed using the Cochrane RoB 2 tool. Trials with low risk of bias were further evaluated. The CONSORT 2010 statement was used to guide standardized reporting, without influencing study selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 340 records identified, 55 were randomized trials. After applying eligibility criteria and excluding studies with high or unclear risk of bias, 15 low-risk trials were included. Overall, PBI demonstrated comparable oncologic outcomes to WBI, with reduced treatment-related burden and improved quality of life in selected patients. However, results varied by technique and fractionation schedule. Notably, the RAPID trial reported higher rates of acute and late skin toxicity and worse cosmetic outcomes with twice-daily 3D external beam PBI, highlighting the importance of technique optimization and appropriate patient selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PBI is a safe and effective alternative to WBI in carefully selected patients with early-stage breast cancer, offering meaningful reductions in toxicity and treatment burden without compromising disease control. Technique-specific considerations remain critical to maximizing both clinical and cosmetic outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyag045","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T12:33:09Z","timestamp":1771158789000},"source":"Crossref","is-referenced-by-count":1,"title":["Partial breast irradiation versus whole breast irradiation after breast-conserving surgery in early-stage breast cancer: a systematic review"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-2843","authenticated-orcid":false,"given":"Sara","family":"Gardu\u00f1o-S\u00e1nchez","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Juan Ram\u00f3n Jimenez University Hospital, Andalusian Health Service , Huelva 21005 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2517-7977","authenticated-orcid":false,"given":"Mar\u00eda Isabel","family":"Villanego-Beltr\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Puerta del Mar University Hospital, Andalusian Health Service, Cadiz 11009 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-7056","authenticated-orcid":false,"given":"Francisco Javier","family":"Carrasco-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Juan Ram\u00f3n Jimenez University Hospital , Andalusian Health Service, Huelva 21005,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-7730","authenticated-orcid":false,"given":"Juan","family":"G\u00f3mez-Salgado","sequence":"additional","affiliation":[{"name":"Department of Sociology, Social Work and Public Health, Faculty of Labour Sciences, University of Huelva , Huelva 21007 ,","place":["Spain"]},{"name":"Safety and Health Postgraduate Programme, Universidad Esp\u00edritu Santo , Guayaquil 092301, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6691-2120","authenticated-orcid":false,"given":"Javier","family":"Ja\u00e9n-Olasolo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Puerta del Mar University Hospital, Andalusian Health Service, Cadiz 11009 ,","place":["Spain"]},{"name":"Biomedical Research and Innovation Institute of C\u00e1diz (INiBICA) Research Unit, Puerta del Mar University Hospital, Andalusian Health Service , Cadiz 11009, Spain ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026031200312985000_oyag045-B1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/genes13060960","article-title":"The history of early breast cancer treatment","volume":"13","author":"Ben-Dror","year":"2022","journal-title":"Genes (Basel)"},{"key":"2026031200312985000_oyag045-B2","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N Engl J Med"},{"key":"2026031200312985000_oyag045-B3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"2026031200312985000_oyag045-B4","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"2026031200312985000_oyag045-B5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiother Oncol"},{"key":"2026031200312985000_oyag045-B6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.clon.2005.07.018","article-title":"A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer","volume":"17","author":"Dodwell","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2026031200312985000_oyag045-B7","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"key":"2026031200312985000_oyag045-B8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ijrobp.2013.08.046","article-title":"Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation","volume":"87","author":"Rodr\u00edguez","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031200312985000_oyag045-B9","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1200\/JCO.2013.50.5511","article-title":"Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy","volume":"31","author":"Olivotto","year":"2013","journal-title":"J Clin Oncol"},{"key":"2026031200312985000_oyag045-B10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.clbc.2020.09.004","article-title":"Preliminary results of a randomized study on postmenopausal women with early stage breast cancer: adjuvant hypofractionated whole breast irradiation versus accelerated partial breast irradiation (HYPAB trial)","volume":"21","author":"Franceschini","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"2026031200312985000_oyag045-B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13014-024-02412-x","article-title":"Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study","volume":"19","author":"Burkon","year":"2024","journal-title":"Radiat Oncol"},{"key":"2026031200312985000_oyag045-B12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial","volume":"51","author":"Livi","year":"2015","journal-title":"Eur J Cancer"},{"key":"2026031200312985000_oyag045-B13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","article-title":"Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europ\u00e9en de Curieth\u00e9rapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)","volume":"94","author":"Polg\u00e1r","year":"2010","journal-title":"Radiother Oncol"},{"key":"2026031200312985000_oyag045-B14","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"2026031200312985000_oyag045-B15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijrobp.2016.05.008","article-title":"Reduced mortality with partial-breast irradiation for early breast cancer: a meta-analysis of randomized trials","volume":"96","author":"Vaidya","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031200312985000_oyag045-B16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.radonc.2014.11.014","article-title":"Accelerated partial irradiation for breast cancer: systematic review and meta-analysis of 8653 women in eight randomized trials","volume":"114","author":"Marta","year":"2015","journal-title":"Radiother Oncol"},{"key":"2026031200312985000_oyag045-B17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","article-title":"Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)","volume":"74","author":"Smith","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031200312985000_oyag045-B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"2026031200312985000_oyag045-B19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost \u2013 GEC-ESTRO Breast Cancer Working Group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"key":"2026031200312985000_oyag045-B20","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"Declaraci\u00f3n PRISMA 2020: una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol"},{"key":"2026031200312985000_oyag045-B21","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2026031200312985000_oyag045-B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2026031200312985000_oyag045-B23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2026031200312985000_oyag045-B24","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026031200312985000_oyag045-B25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.medcli.2010.09.034","article-title":"Declaraci\u00f3n CONSORT 2010: actualizaci\u00f3n de la lista de comprobaci\u00f3n para informar ensayos cl\u00ednicos aleatorizados de grupos paralelos","volume":"137","author":"Cobos-Carb\u00f3","year":"2011","journal-title":"Med Cl\u00edn"},{"key":"2026031200312985000_oyag045-B26","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","article-title":"The European organization for research and treatment of cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study","volume":"14","author":"Sprangers","year":"1996","journal-title":"J Clin Oncol"},{"key":"2026031200312985000_oyag045-B27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00520-014-2383-0","article-title":"The Spanish version of the Body Image Scale (S-BIS): psychometric properties in a sample of breast and gynaecological cancer patients","volume":"23","author":"G\u00f3mez-Campelo","year":"2015","journal-title":"Support Care Cancer"},{"key":"2026031200312985000_oyag045-B28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jphys.2023.03.005","article-title":"Clinimetrics: functional assessment of chronic illness therapy-fatigue (FACIT-fatigue)","volume":"69","author":"Ilsley","year":"2023","journal-title":"J Physiother"},{"key":"2026031200312985000_oyag045-B29","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"2026031200312985000_oyag045-B30","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(18)30195-5","article-title":"Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial","volume":"19","author":"Sch\u00e4fer","year":"2018","journal-title":"Lancet Oncol"},{"key":"2026031200312985000_oyag045-B31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13014-020-01581-9","article-title":"Fatigue following radiotherapy of low-risk early breast cancer\u2013a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)","volume":"15","author":"Forster","year":"2020","journal-title":"Radiat Oncol"},{"key":"2026031200312985000_oyag045-B32","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026031200312985000_oyag045-B33","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"key":"2026031200312985000_oyag045-B34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","article-title":"Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial","volume":"383","author":"Vaidya","year":"2014","journal-title":"Lancet"},{"key":"2026031200312985000_oyag045-B35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.radonc.2013.05.008","article-title":"Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the budapest randomized trial","volume":"108","author":"Polg\u00e1r","year":"2013","journal-title":"Radiother Oncol"},{"key":"2026031200312985000_oyag045-B36","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s12094-021-02618-5","article-title":"Long-term results of a randomized partial irradiation trial compared to whole breast irradiation in the early stage and low-risk breast cancer patients after conservative surgery","volume":"23","author":"Li","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"2026031200312985000_oyag045-B37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","article-title":"5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"key":"2026031200312985000_oyag045-B38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1470-2045(17)30011-6","article-title":"Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial","volume":"18","author":"Polg\u00e1r","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026031200312985000_oyag045-B39","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ijrobp.2020.11.006","article-title":"Breast-conserving surgery followed by partial or whole breast irradiation: twenty-year results of a phase 3 clinical study","volume":"109","author":"Polg\u00e1r","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031200312985000_oyag045-B40","doi-asserted-by":"publisher","first-page":"m2836","DOI":"10.1136\/bmj.m2836","article-title":"Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial","volume":"370","author":"Vaidya","year":"2020","journal-title":"BMJ"},{"key":"2026031200312985000_oyag045-B41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.radonc.2016.06.019","article-title":"GEC-ESTRO multicenter phase 3-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance","volume":"120","author":"Ott","year":"2016","journal-title":"Radiother Oncol"},{"key":"2026031200312985000_oyag045-B42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1470-2045(23)00018-9","article-title":"Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial","volume":"24","author":"Strnad","year":"2023","journal-title":"Lancet Oncol"},{"key":"2026031200312985000_oyag045-B43","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41598-025-85342-2","article-title":"Quality of life in early breast cancer patients after adjuvant accelerated partial-breast irradiation (APBI) in randomized trial","volume":"15","author":"Burkon","year":"2025","journal-title":"Sci Rep"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/advance-article-pdf\/doi\/10.1093\/oncolo\/oyag045\/66960512\/oyag045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/4\/oyag045\/66960512\/oyag045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/31\/4\/oyag045\/66960512\/oyag045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:31:50Z","timestamp":1773289910000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyag045\/8488756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyag045","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,2,17]]},"article-number":"oyag045"}}